Mannkind (MNKD) Change in Accured Expenses (2010 - 2026)
Mannkind (MNKD) reported Change in Accured Expenses of -$5.8 million for Q1 2026, down 4406.72% year-over-year from $134000.0 in Q1 2025, and down 143.23% quarter-over-quarter from $13.4 million in Q4 2025.
Mannkind (MNKD) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Change in Accured Expenses data on file, last reported at -$5.8 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$5.8 million, down 4406.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 18.22% YoY), and the FY2025 annual result was $3.3 million, up 220.46% from the prior year.
- Change in Accured Expenses fell to -$5.8 million in Q1 2026 per MNKD's latest filing, from $13.4 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $13.4 million in Q4 2025 and troughed at -$9.5 million in Q2 2025.
- A 5-year average of $39117.6 and a median of -$644000.0 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2026: Change in Accured Expenses jumped 769.45% in 2023, then sank 4406.72% in 2026.
- A 5-year view of Change in Accured Expenses shows it stood at -$1.6 million in 2022, then jumped by 769.45% to $10.4 million in 2023, then sank by 79.81% to $2.1 million in 2024, then surged by 533.9% to $13.4 million in 2025, then plunged by 143.23% to -$5.8 million in 2026.
- Business Quant data shows MNKD's Change in Accured Expenses at -$5.8 million in Q1 2026, $13.4 million in Q4 2025, and -$761000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -5.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.77 Mn |
| Mar 31, 2026 | -5.77 Mn |
| Dec 31, 2025 | 13.35 Mn |
| Dec 31, 2025 | 13.35 Mn |
| Sep 30, 2025 | -761,000.00 |
| Sep 30, 2025 | -761,000.00 |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | 134,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 2.11 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 670,000.00 |
| Mar 31, 2024 | 670,000.00 |
| Dec 31, 2023 | 10.43 Mn |
| Dec 31, 2023 | 10.43 Mn |